Prediction of neuroleptic-induced dystonia

Neuroleptic malignant syndrome: recognizing an unrecognized killer.

Journal of psychosocial nursing and mental health services·1989

Concomitant treatment of neuroleptic malignant syndrome and psychosis.

The British journal of psychiatry : the journal of mental science·1989

Neuroleptic malignant syndrome.

American family physician·1988

The Randomization Effect in a Double-Blind Placebo-Controlled Depression Study.

Journal of clinical psychopharmacology·2026

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal of clinical psychopharmacology·2026

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Journal of clinical psychopharmacology·2026

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

Journal of clinical psychopharmacology·2026

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Journal of clinical psychopharmacology·2026

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Journal of clinical psychopharmacology·2026

Expanding Quantitative Medicines' Reach: Systems and Methods to Enhance R&D Productivity and Decision-Making in the Agentic-Era.

Clinical and translational science·2026

Physiologically Based Pharmacokinetic Modeling to Assess Transporter-Mediated Drug-Drug Interactions in Support of Labeling Recommendations for Zavegepant Nasal Spray.

Clinical pharmacology and therapeutics·2026

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.

Regulatory toxicology and pharmacology : RTP·2026

Structural determinants of Mac1 inhibition: Lessons from ligand binding patterns.

International journal of biological macromolecules·2026

A deep learning framework for oligopeptide candidate discovery across metabolism-related contexts.

Cell reports methods·2026

Structural basis of MRP2 interactions with substrate and inhibitor.

Structure (London, England : 1993)·2026

Related Experiment Videos

Prediction of neuroleptic-induced dystonia

Related Concept Videos

Neuroleptic malignant syndrome: recognizing an unrecognized killer.

Concomitant treatment of neuroleptic malignant syndrome and psychosis.

Neuroleptic malignant syndrome.

The Randomization Effect in a Double-Blind Placebo-Controlled Depression Study.

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Expanding Quantitative Medicines' Reach: Systems and Methods to Enhance R&D Productivity and Decision-Making in the Agentic-Era.

Physiologically Based Pharmacokinetic Modeling to Assess Transporter-Mediated Drug-Drug Interactions in Support of Labeling Recommendations for Zavegepant Nasal Spray.

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.

Structural determinants of Mac1 inhibition: Lessons from ligand binding patterns.

A deep learning framework for oligopeptide candidate discovery across metabolism-related contexts.

Structural basis of MRP2 interactions with substrate and inhibitor.

Related Experiment Videos

Prediction of neuroleptic-induced dystonia

Related Concept Videos

Related Articles